C1 Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis

Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis

Download - PDF

ABSTRACT

Objectives:

Andrographis paniculata has in vitro inhibitory activity against TNF-a, IL-1p and NF-KB. A pilot study of A. paniculata extract (HMPL-004) suggested similar ef.cacy to mesalamine for ulcerative colitis.

Methodes:

A randomized, double-blind, placebo-controlled trial evaluated the ef.cacy of A. paniculata extract (HMPL-004) in 224 adults with mild-to-moderate ulcerative colitis. Patients were randomized to A. paniculata extract (HMPL-004) 1,200 mg or 1,800 mg daily or placebo for 8 weeks.

Results:

In total, 45 and 60 % of patients receiving A. paniculata 1,200 mg and 1,800 mg daily, respectively, were in clinical response at week 8, compared with 40 % of those who received placebo (P=0.5924 for 1,200 mg vs. placebo and P=0.0183 for 1,800 mg vs. placebo). In all, 34 and 38 % of patients receiving A. paniculata 1,200 mg and 1,800 mg daily, respectively, were in clinical remission at week 8, compared with 25 % of those who received placebo (P=0.2582 for 1,200 mg vs. placebo and P=0.1011 for 1,800 mg vs. placebo). Adverse events developed in 60 and 53 % of patients in the A. paniculata 1,200 mg and 1,800 mg daily groups, respectively, and 60 % in the placebo group.

Results:

Patients with mildly to moderately active ulcerative colitis treated with A. paniculata extract (HMPL-004) at a dose of 1,800 mg daily were more likely to achieve clinical response than those receiving placebo.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538174/

gallmet.hu
en_GBEnglish (UK)
Privacy Overview
gallmet.hu

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website collects anonymous information through the use of third-party cookies (Ad-related cookies and Performance cookies)